Kheradmand MD Assistant Professor of Shahid Beheshti Medical University When does anxiety become a disorder Anxiety is a normal human response to objects situations or events that are threatening ID: 702320
Download Presentation The PPT/PDF document "Anxiety Disorders Dr Ali" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
Anxiety Disorders
Dr
Ali
Kheradmand
M.D.
Assistant Professor
of
Shahid
Beheshti
Medical UniversitySlide2
When does anxiety become a disorder?
Anxiety is a normal human response to objects, situations or events that are threatening
Anxiety is different from fear due to its cognitive component (i.e. fear of the future)
Anxiety can be helpful and adaptive (e.g. anxiety about giving lectures!)
Anxiety becomes a disorder when out of proportion or when it significantly interferes with life.Slide3
Anxiety disorders…
Highly treatable yet also resistant to extinction
Often begins early in life
Reported more by women than men
Reported more in Western countries
Often comorbid both with other anxiety diagnoses and with other disorder groups (e.g. Mood disorders, psychoses)Slide4
General considerations for anxiety disorders
Often have an early onset- teens or early twenties
Show 2:1 female predominance
Have a waxing and waning course over lifetime
Similar to major depression and chronic diseases such as diabetes in functional impairment and decreased quality of lifeSlide5
There Are Two Types Of Anxiety:
Anticipatory
: feeling of distress occurring while studying for or thinking about the exam.
Situational:
feeling of distress occurring while taking the exam.
It is important to be aware of when anxiety attacks you so that you may use strategies in and out of the exam situation to manage the anxiety.Slide6
Test anxiety affects you in three ways:
Physiologically
Behaviorally
Psychologically
How does test anxiety affect you?Slide7
Sensory Input
2. Amygdala registers danger
3. Amygdala triggers fast response
4. More considered response based on cortical processing
1. Thalamus receives stimulus and sends to both amygdala and cortex
Parts of the brain involved in fear response = thalamus, amygdala, hypothalamus, which then instruct the endocrine glands and autonomic nerv.sys.
Evolved fear module (pink) versus considered response (green) = “fight or flight” versus “feel the fear and do it anyway (or do it differently)”!Slide8
8Slide9
Physiological reactions may include:
- increased heartbeat
- tensed muscles
- perspiration
- dry mouthSlide10
Behavioral reactions may include:
-
Inability to make decisions, act, or express yourself.
-
Difficulty reading and understanding questions on an exam.
- Difficulty organizing your thoughts.
- Difficulty recalling or retrieving terms and concepts.
Slide11
Psychological reactions may include:
- Feeling apprehensive or uneasy.
- Feeling upset.
- Having self-doubt or negative self-talk
.Slide12
12Slide13
The differential diagnosis of anxiety. Psychiatric and Medical disorders.
Psychiatr
Clin
North Am 1985 Mar;8(1):3-23
Primary versus Secondary Anxiety
Anxiety may be due to one of the primary anxiety disorders OR secondary to substance abuse (Substance-Induced Anxiety Disorder), a medical condition (Anxiety Disorder Due to a General Medical Condition), another psychiatric condition, or psychosocial stressors (Adjustment Disorder with Anxiety)Slide14
The Anxiety Disorders
Specific Phobia
Social Phobia
Panic Disorder without agoraphobia
Panic Disorder with agoraphobia
Obsessive-Compulsive Disorder
Substance induced Anxiety Disorder
Post-traumatic Stress Disorder
Generalized Anxiety Disorder
Anxiety Disorder due to a general medical condition
Anxiety Disorder Not otherwise specifiedSlide15
Epidemiology of anxiety disorders
Damsa C. et al. Current status of brain imaging in anxiety disorders. Curr Opin Psychiatry 2009;22:96-110Slide16
Specific Phobias
Selective, persistent and out of proportion
Includes cognition that leads to behavioural response, whether or not the threat is present
May be genetically, neurologically or experientially based
Maintained through the processes of classical and operant conditioning.Slide17
Specific Phobia
Epidemiology
Up to 15% of general population
Onset early in life
Female:Male
2:1
Etiology
Learning, contextual conditioning
Treatment
Systematic desensitizationSlide18
Social Phobia
A more pervasive, highly cognitive type of phobia
Distinguishing feature is the fear of doing something
in front of others
May be situation or context (e.g. performance versus interaction anxiety) specific
Fear of one’s own behaviour causing negative attention from othersSlide19
Incidence of social anxiety disorders and the consistent risk for secondary depression in the first three decades of life. Arch Gen Psychiatry 2007 Mar(4):221-232
Social Phobia Epidemiology
7% of general population
Age of onset teens; more common in women. Stein found half of SAD patients had onset of sx by age 13 and 90% by age 23.
Causes significant disability
Increased depressive disorders Slide20
What is going on in their brains??
Both groups ↑ medial
prefrontal
cortex
activity in response to intentional relative to unintentional transgression.
SAD patients however showed a significant response to the unintentional transgression.
SAD subjects also had significant increase activity in the
amygdala
and
insula
bilaterally.
Blair K. Et al. Social Norm Processing in Adult Soical Phobia: Atypical Increased Ventromedial Frontal cortex Responsiveness to Unintentional (Embarrasing) Trasgressions. Am J Psychiatry 2010;167:1526-1532Slide21
What is going on in their brains??
Blair K. Et al. Social Norm Processing in Adult Soical Phobia: Atypical Increased Ventromedial Frontal cortex Responsiveness to Unintentional (Embarrasing) Trasgressions. Am J Psychiatry 2010;167:1526-1532Slide22
Agoraphobia
Marked fear or anxiety for more than 6 months about two or more of the following 5 situations:
Using public transportation
Being in open spaces
Being in enclosed spaces
Standing in line or being in a crowd
Being outside of the home aloneSlide23
Agoraphobia
The individual fears or avoids these situations because escape might be difficult or help might not be available
The agoraphobic situations almost always provoke
anxiety
Anxiety is out of proportion to the actual threat posed by the situation
The agoraphobic situations are
avoided or endured with
intense anxiety
The
avoidance, fear or
anxiety
significantly interferes with their routine or functionSlide24
Prevalence
2% of the population
Females to males:2:1
Mean onset is 17 years
30% of persons with agoraphobia have panic attacks or panic disorder
Confers higher risk of other anxiety disorders, depressive and substance-use disordersSlide25
Panic Disorder
Two major types: with or without agoraphobia
Consists of a pattern of
recurring
panic attacks
Emotional, physical, cognitive and behavioural components
Main fear is of losing control
(consequence = dying, going crazy, embarrassment, not being able to get help)
The
fear
of having a panic attack becomes a problem of itself, possibly leading to agoraphobia (fear of open spaces, crowds etc. Any place where escape or finding help is difficult or embarrassing) or other phobiasSlide26
A Panic Attack is:
Palpitations or rapid heart rate
Sweating
Trembling or shaking
Shortness of breath
Feeling of choking
Chest pain or discomfort
Nausea
Chills or heat sensations
Paresthesias
Feeling dizzy or faint
Derealization or depersonalization
Fear of losing control or going crazy
Fear of dying
A discrete period of intense fear in which 4 of the following
Symptoms abruptly develop and peak within 10 minutes:Slide27
Panic disorder epidemiology
2-3% of general population; 5-10% of primary care patients ---Onset in teens or early 20
’
s
Female:male 2-3:1Slide28
Things to keep in mind
A panic attack ≠ panic disorder
Panic disorder often has a waxing and waning courseSlide29
Post Traumatic Stress Disorder
Is it an anxiety disorder?
Main diagnostic criteria:
Witness or experience of an event that (a) involved actual or threatened death or injury,
and
Feelings of intense fear, horror, or helplessness
Person must relive the event in some way (e.g. dreams, “flashbacks”, internal distress, physiological reactions)
Avoidance (subconscious and/or conscious)
Hyperarousal or mood instability
Usually persisting for at least three monthsSlide30
Generalized Anxiety Disorder
Excessive worry more days than not for at least 6 months about a number of events and they find it difficult to control the worry.
3 or more of the following symptoms:
Restlessness or feeling keyed up or on edge, easily fatigued, difficulty concentrating, irritability, muscle tension, sleep disturbance
Causes significant distress or impairmentSlide31
Generalized Anxiety Disorder Epidemiology
4-7% of general population
Median onset=30 years but large range
Female:Male
2:1 Slide32
OCD Comorbidities
>70% have lifetime dx of an anxiety disorder such as PD, SAD, GAD, phobia
>60% have lifetime dx of a mood disorder MDD being the most common
Up to 30% have a lifetime Tic disorder
12% of persons with schizophrenia/ schizoaffective disorderSlide33
Obsessive Compulsive Disorder
Classified as anxiety disorder, but with unique presentation
Characterised by obsessions
and
compulsions (in most cases)
Compulsions may be physical or mental
Types of presentation: contamination fear; doubt/checking; magic thinking; symmetry; hoarding
Severity = frequency + capacity to resist + interference with normal functioningSlide34
OCD Etiology
Genetics
Serotonergic dysfunction
Cortico-striato-thalamo-cortical loop
Autoimmune- PANDASSlide35
Treatment
40-60% treatment response
Serotonergic antidepressants
Behavior therapy
Adjunctive antipsychotics, psychosurgery
PANDAS – penicillin,
plasmapharesis
, IV immunoglobulinSlide36
Functional imaging studies
Increased activity in the right
caudate
is found in pts with OCD and Cognitive behavior therapy reduces resting state glucose metabolism or blood flow in the right caudate in treatment responders.
Similar results have been obtained with pharmacotherapy
Baxter L. et al. Caudate glucose metabolic rate changes with both drug and behavioral therapy for obessive-compulsive disorder. Arch Gen Psych 1992;49:681-689Slide37
Anxiety
Disorders
37
Possible Causes
Tourette
’
s syndrome
is characterized by muscular and vocal tics: facial grimaces, squatting, pacing, twirling, barking, sniffing, coughing, grunting, or repeating specific words (especially vulgarities).
Tourette
’
s Syndrome
a neurological disorder characterized by tics and involuntary vocalizations and sometimes by compulsive uttering of obscenities and repetition of the utterances of othersSlide38
Trauma- and Stressor-Related Disorders
Acute Stress Disorder
Adjustment Disorders
Posttraumatic Stress DisorderSlide39
PTSD continued
Presence of 1 or more intrusive
sx
after the event
Recurrent, involuntary and intrusive memories of event
Recurrent trauma-related nightmares
Dissociative reactions
Intense
physiologic distress
at cue exposure
Marked physiological
reactivity at cue exposure
Persistent avoidance by 1 or both:
Avoidance of distressing memories, thoughts or feelings of the event(s)
Avoidance of external reminders of that arouse memories of event(s) e.g. people, places, activitiesSlide40
Negative alterations in cognitions and mood associated with the traumatic event(s) as evidenced by 2 or more of the following:
Inability to remember an important aspect of the traumatic event(s)
Persistent distorted cognitions about cause or consequence of event that lead to blame of self or others
Persistent negative emotional state
Marked diminished interest
Feeling detached from others
Persistent inability to experience positive emotionsSlide41
Marked alterations in arousal and reactivity with 2 or more of:
Irritable behavior and and angry outbursts
Reckless or self-destructive behavior
Hypervigilance
Exaggerated startle response
Problems with concentration
Sleep disturbanceSlide42
Duration of disturbance is more than one month AND causes significant impairment in function
Specifiers:
With dissociative sx (derealization or depersonalization)
With delayed expression (don
’
t meet criteria until >6 months after event)Slide43
PTSD Epidemiology
7-9% of general population
60-80% of trauma victims
30% of combat veterans
50-80% of sexual assault victims
Increased risk in women, younger people
Risk increases with
“
dose
”
of trauma, lack of social support, pre-existing psychiatric disorderSlide44
Comorbidities
Depression
Other anxiety disorders
Substance use disorders
Somatization
Dissociative disorders Slide45
Functional neuroimaging in PTSD
Increased
amygdal
activation is seen in PTSD pts compared to controls
Hypoactivation
of the medial prefrontal cortex including the
orbitofrontal
cortex
and
anterior
cingulate cortex (area implicated in affect regulation)
Francati V. et al. Functional Neuroimaging Studies in Posttraumatic Stress Disorder:Review of Current methods and Findings. Depression and Anxiety 2007;24:202-218Slide46
Study found treatment of PTSD with paroxetine resulted in increased anterior cingulate cortex function
Fani N. et al. Increased neural response to trauma scripts in posttraumatic stress disorder following paroxetine treatment: A pilot study. Neurosci Letters 2011;491:196-201Slide47
Acute Stress Disorder
Similar exposure as in PTSD
Presence of
>
9 of 5 categories of intrusion, negative mood, dissociation, avoidance, and arousal related to the trauma.
Duration of disturbance is 3 days to 1 month after trauma
Causes significant impairment Slide48
General treatment approaches
Pharmacotherapy
Antidepresssants
Anxiolytics
Antipsychotics
Mood stabilizers
Psychotherapy- Cognitive Behavior TherapySlide49
Crank up the serotonin
Cornerstone of treatment for anxiety disorders is increasing serotonin
Any of the SSRIs or SNRIs can be usedSlide50
How to use them
Start at ½ the usual dose used for antidepressant benefit i.e citalopram at 10mg rather than the usual 20mg
WARN THEM THEIR ANXIETY MAY GET WORSE BEFORE IT GETS BETTER!!
May need to use an anxiolytic while initiating and titrating the antidepressantSlide51
Other options
Hydroxyzine
- usually 50mg
prn
. Helpful for some patients but has prominent
anticholinergic
SEs
Buspirone
-For GAD- 60mg daily
Propranolol
-Effective for discrete social phobia i.e. performance anxiety
Atypical antipsychotics at low doses for augmentation in difficult to treat OCD ptsSlide52
Anticonvulsants
Valproic acid 500-750 mg bid (ending dose)
carbamazepine 200-600 mg bid (ending dose)
Gabapentin 900-2700 mg daily in 3 divided doses (ending dose)
Atypical antipsychotics at low doses for augmentation in difficult to treat OCD ptsSlide53
Mothers little helpers
Benzodiazapines are very effective in reducing anxiety sx however due to the risk of dependence must use with caution
Depending on the patient may either use on a prn basis or scheduled
DO NOT USE ALPRAZOLAM- talk about a reinforcing drug!
For patients with a history of addiction or active drug/ETOH abuse or dependence benzodiazepines are not an optionSlide54
Alternative
Treatments
Acupuncture
Aromatherapy
Breathing Exercises
Exercise
Meditation
Nutrition and Diet Therapy
Vitamins
Self Love